Bacil Pharma Ltd Board Approves ₹50 Cr Rights Issue, Director Resignations

Bacil Pharma Ltd's Board of Directors has approved a Rights Issue to raise up to ₹50 crore. The company also approved an increase in its authorized share capital to ₹65 crore. In addition, the board accepted the resignations of two Independent Directors, Mr. Dinesh Chander Notiyal and Ms. Avani Savjibhai Godhaniya, citing pre-occupation with other assignments. Intermediaries for the Rights Issue, including a registrar, banker, and monitoring agency, have been appointed. A Rights Issue Committee has been formed, and Ms. Chaitali Kalpataru Shah (Executive Director & CFO) and the Company Secretary have been authorized to handle the issue's documentation.